Elutia
1 known investors
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
BiotechHealthtechMedical Devices
Founders & leadership
CR
C. Randal MillsFounder, President & CEO
Investors · 1
Frequently asked questions
- What does Elutia do?
- Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
- Who founded Elutia?
- Elutia was founded by C. Randal Mills.
- Who are Elutia's investors?
- Elutia's investors include HighCape Capital.